Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)
Clara Sebbag, Christine Rousset-Jablonski, Florence Coussy, Isabelle Ray-Coquard, Clémentine Garin, Clémence Evrevin, Aullène Toussaint, Marion Cessot, Julie Labrosse, Lucie Laot, Lauren Darrigues, Angélique Bobrie, William Jacot, Claire Sénéchal-Davin, Marc Espié, Sylvie Giacchetti, Patrick Charveriat, Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Anne Gompel, Charles Chapron, Pietro Santulli, Bernard Asselain, Judicaël Hotton, Charles Coutant, Julien Guerin, Christine Decanter, Audrey Mailliez, Lidia Delrieu, Elise Dumas, Laura Sablone, Research Network Seintinelles, Fabien Reyal, Anne-Sophie Hamy
doi: https://doi.org/10.1101/2021.12.15.21267867
Clara Sebbag
1Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
Christine Rousset-Jablonski
3INSERM U1290 RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France
4Department of Surgical Oncology, Centre Léon Bérard, Lyon, France
Florence Coussy
1Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Isabelle Ray-Coquard
3INSERM U1290 RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France
4Department of Surgical Oncology, Centre Léon Bérard, Lyon, France
Clémentine Garin
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
Clémence Evrevin
1Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Aullène Toussaint
1Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Marion Cessot
4Department of Surgical Oncology, Centre Léon Bérard, Lyon, France
Julie Labrosse
5Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Lucie Laot
5Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Lauren Darrigues
5Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
Angélique Bobrie
6Department of Medical Oncology, Institut du cancer de Montpellier, Montpellier, France
William Jacot
6Department of Medical Oncology, Institut du cancer de Montpellier, Montpellier, France
Claire Sénéchal-Davin
7Department of Oncogenetics, Institut Bergonié, Bordeaux, France
Marc Espié
8Sénolopole, Hôpital Saint Louis, AP-HP, Paris, France; University Paris, Paris France
Sylvie Giacchetti
8Sénolopole, Hôpital Saint Louis, AP-HP, Paris, France; University Paris, Paris France
Patrick Charveriat
8Sénolopole, Hôpital Saint Louis, AP-HP, Paris, France; University Paris, Paris France
Geneviève Plu-Bureau
9Department of Gynecology, Hôpital Cochin, Paris, France; University Paris, Paris France
Lorraine Maitrot-Mantelet
9Department of Gynecology, Hôpital Cochin, Paris, France; University Paris, Paris France
Anne Gompel
9Department of Gynecology, Hôpital Cochin, Paris, France; University Paris, Paris France
Charles Chapron
9Department of Gynecology, Hôpital Cochin, Paris, France; University Paris, Paris France
Pietro Santulli
9Department of Gynecology, Hôpital Cochin, Paris, France; University Paris, Paris France
Bernard Asselain
10Department of Biostatistics, Unicancer, Paris, France
Judicaël Hotton
11Department of Surgical Oncology, Institut Godinot, Reims, France
Charles Coutant
12Department of Surgical Oncology, Centre Georges-François Leclerc - Unicancer, Dijon, France
13Clinical Research Department, Centre Georges-François Leclerc - Unicancer, Dijon, France
Julien Guerin
14Data Factory, Data Office, Institut Curie, 25 rue d’Ulm, 75005 Paris, France
Christine Decanter
15ART department, Centre Hospitalier Regional Lille, Lille, France
Audrey Mailliez
16Department of Medical Oncology, Centre Oscar Lambert, Lille, France
Lidia Delrieu
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
Elise Dumas
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
Laura Sablone
17Seintinelles Research Network, 40 Rue Rémy Dumoncel, 75014 Paris
17Seintinelles Research Network, 40 Rue Rémy Dumoncel, 75014 Paris
Fabien Reyal
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
5Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
17Seintinelles Research Network, 40 Rue Rémy Dumoncel, 75014 Paris
Anne-Sophie Hamy
1Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France
5Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
17Seintinelles Research Network, 40 Rue Rémy Dumoncel, 75014 Paris
Article usage
Posted December 16, 2021.
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)
Clara Sebbag, Christine Rousset-Jablonski, Florence Coussy, Isabelle Ray-Coquard, Clémentine Garin, Clémence Evrevin, Aullène Toussaint, Marion Cessot, Julie Labrosse, Lucie Laot, Lauren Darrigues, Angélique Bobrie, William Jacot, Claire Sénéchal-Davin, Marc Espié, Sylvie Giacchetti, Patrick Charveriat, Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Anne Gompel, Charles Chapron, Pietro Santulli, Bernard Asselain, Judicaël Hotton, Charles Coutant, Julien Guerin, Christine Decanter, Audrey Mailliez, Lidia Delrieu, Elise Dumas, Laura Sablone, Research Network Seintinelles, Fabien Reyal, Anne-Sophie Hamy
medRxiv 2021.12.15.21267867; doi: https://doi.org/10.1101/2021.12.15.21267867
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)
Clara Sebbag, Christine Rousset-Jablonski, Florence Coussy, Isabelle Ray-Coquard, Clémentine Garin, Clémence Evrevin, Aullène Toussaint, Marion Cessot, Julie Labrosse, Lucie Laot, Lauren Darrigues, Angélique Bobrie, William Jacot, Claire Sénéchal-Davin, Marc Espié, Sylvie Giacchetti, Patrick Charveriat, Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Anne Gompel, Charles Chapron, Pietro Santulli, Bernard Asselain, Judicaël Hotton, Charles Coutant, Julien Guerin, Christine Decanter, Audrey Mailliez, Lidia Delrieu, Elise Dumas, Laura Sablone, Research Network Seintinelles, Fabien Reyal, Anne-Sophie Hamy
medRxiv 2021.12.15.21267867; doi: https://doi.org/10.1101/2021.12.15.21267867
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (632)
- Anesthesia (168)
- Cardiovascular Medicine (2400)
- Dermatology (207)
- Emergency Medicine (381)
- Epidemiology (11799)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3769)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2409)
- Health Policy (940)
- Hematology (342)
- HIV/AIDS (787)
- Medical Education (369)
- Medical Ethics (105)
- Nephrology (401)
- Neurology (3524)
- Nursing (199)
- Nutrition (529)
- Oncology (1835)
- Ophthalmology (539)
- Orthopedics (221)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1038)
- Primary Care Research (424)
- Public and Global Health (6184)
- Radiology and Imaging (1291)
- Respiratory Medicine (832)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (406)
- Toxicology (50)
- Transplantation (172)
- Urology (147)